Novartis Investigative Site

Worcester WR5 1DD

0 studies enrolling now · 5 studies all time

What they study most

Acute Myocardial Infarction, Atherosclerosis, Atherosclerotic Cardiovascular Disease, Chronic Heart Failure With Reduced Ejection Fraction, Familial Hypercholesterolemia, Heart Failure With Reduced Ejection Fraction, Symptomatic Atherosclerosis, Type2 Diabetes

Studies at this site

• Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI — Completed
• An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early